Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life
Publication Date
5-1-2022
Journal
Journal of the Advanced Practitioner in Oncology
Abstract
Hemophilia A is a rare inherited bleeding disorder characterized by a deficiency in factor VIII. The evolution of currently approved prophylaxis therapy in hemophilia A will be reviewed, including the clinical value of prophylaxis, real-world experience with prophylaxis, and patient quality-of-life factors that must be considered when choosing treatment options for these patients.